Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Renal Insufficiency, Chronic 1Lymphoma, Follicular 1Diabetes Mellitus 1

Interventions

Rituximab 1372Cyclophosphamide 1299Vincristine 664Doxorubicin 585Etoposide 525Prednisone 506Cytarabine 482fludarabine 462Methotrexate 442Dexamethasone 412fludarabine phosphate 396Lenalidomide 347Filgrastim 342Bendamustine Hydrochloride 275Radiotherapy 266venetoclax 255ibrutinib 249Peripheral Blood Stem Cell Transplantation 233Melphalan 229obinutuzumab 228Granulocyte Colony-Stimulating Factor 212Bortezomib 204Gemcitabine 201Busulfan 186Whole-Body Irradiation 185Mycophenolic Acid 174Tacrolimus 164Specimen Handling 163Magnetic Resonance Spectroscopy 151Calcium Dobesilate 151

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × DM199 × Lymphoid × Clear all
NCT03795389 2021-09-13

Study to Assess PK, Safety and Tolerability in Patients With DM and CKD

DiaMedica Therapeutics Inc

Phase 1 Completed
33 enrolled
Lymphoid

Diabetes Mellitus, Lymphoma, Follicular, Renal Insufficiency, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡